GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.95
-0.05 (-0.28%)
Mar 24, 2026, 1:30 PM CST

TPE:3164 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
401.23385.37318.02368.55427.93
Revenue Growth (YoY)
4.11%21.18%-13.71%-13.88%31.59%
Cost of Revenue
149.6147.19106.82111.83128.6
Gross Profit
251.63238.18211.19256.72299.33
Selling, General & Admin
147.82152.79156.6137.12145.47
Research & Development
45.3445.2746.8659.4125.52
Operating Expenses
193.88197.55204.2194.75174.29
Operating Income
57.7540.636.9961.97125.04
Interest Expense
-3.92-3.72-0.97-0.76-0.77
Interest & Investment Income
7.0611.69.464.82.35
Currency Exchange Gain (Loss)
-17.05-6.9810.45-1.35
Other Non Operating Income (Expenses)
2.790.40.34-1.981.06
EBT Excluding Unusual Items
63.6865.978.8374.48126.34
Gain (Loss) on Sale of Investments
--1.2319.05-8.169.35
Gain (Loss) on Sale of Assets
--0.020.28-0.063.74
Pretax Income
63.6864.7228.1666.26139.42
Income Tax Expense
15.716.975.7318.829.82
Earnings From Continuing Operations
47.9847.7522.4347.46109.6
Net Income to Company
47.9847.7522.4347.46109.6
Minority Interest in Earnings
9.229.510.569.523.53
Net Income
57.257.2532.9956.98113.13
Net Income to Common
57.257.2532.9956.98113.13
Net Income Growth
-0.09%73.53%-42.10%-49.64%85.82%
Shares Outstanding (Basic)
8787868686
Shares Outstanding (Diluted)
8787878787
Shares Change (YoY)
-0.07%0.18%-0.10%-0.09%-1.50%
EPS (Basic)
0.660.660.380.661.31
EPS (Diluted)
0.660.660.380.661.30
EPS Growth
-73.68%-42.40%-49.25%88.41%
Free Cash Flow
70.1979.891.2965.79-5.28
Free Cash Flow Per Share
0.810.920.010.76-0.06
Dividend Per Share
-0.8000.5000.7001.100
Dividend Growth
-60.00%-28.57%-36.36%57.14%
Gross Margin
62.72%61.80%66.41%69.66%69.95%
Operating Margin
14.39%10.54%2.20%16.81%29.22%
Profit Margin
14.26%14.86%10.37%15.46%26.44%
Free Cash Flow Margin
17.49%20.73%0.41%17.85%-1.23%
EBITDA
124.71108.1868.77109.92143.05
EBITDA Margin
31.08%28.07%21.63%29.82%33.43%
D&A For EBITDA
66.9667.5561.7947.9518.02
EBIT
57.7540.636.9961.97125.04
EBIT Margin
14.39%10.54%2.20%16.81%29.22%
Effective Tax Rate
24.65%26.22%20.35%28.37%21.39%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.